Increased Framingham risk score associated with poor outcomes in people with multiple sclerosis


  • An increased Framingham risk score at baseline was associated with a greater risk of relapses, disability and escalation of disease-modifying treatment (DMT) in people with multiple sclerosis (MS).

Why this matters

  • The impact of multiple cardiovascular risk factors using the Framingham risk score in people with MS has not been assessed.

  • The results of this novel study may help with the long-term management of MS.